![]() |
Volumn 11, Issue 8, 2001, Pages 647-653
|
Influence of the dopamine D2 receptor (DRD2) exon 8 genotype on efficacy of tiapride and clinical outcome of alcohol withdrawal
a
|
Author keywords
Depression; DRD2; Tiapride; Withdrawal
|
Indexed keywords
APOMORPHINE;
CARBAMAZEPINE;
CLOMETHIAZOLE;
DIAZEPAM;
DOPAMINE 2 RECEPTOR;
DOPAMINE 2 RECEPTOR STIMULATING AGENT;
TIAPRIDE;
ALCOHOL;
DOPAMINE RECEPTOR BLOCKING AGENT;
ADULT;
ALCOHOL WITHDRAWAL;
ALLELE;
ANXIETY NEUROSIS;
ARTICLE;
CAUCASIAN;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DETOXIFICATION;
DISEASE COURSE;
DOPAMINERGIC SYSTEM;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
GENETIC VARIABILITY;
GENOTYPE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
TITRIMETRY;
TREATMENT OUTCOME;
EXON;
GENETICS;
POINT MUTATION;
PSYCHOLOGICAL ASPECT;
WITHDRAWAL SYNDROME;
ADULT;
DOPAMINE ANTAGONISTS;
ETHANOL;
EXONS;
FEMALE;
GENOTYPE;
HUMANS;
MALE;
POINT MUTATION;
RECEPTORS, DOPAMINE D2;
SUBSTANCE WITHDRAWAL SYNDROME;
TIAPRIDE;
TREATMENT OUTCOME;
|
EID: 0034746993
PISSN: 0960314X
EISSN: None
Source Type: Journal
DOI: 10.1097/00008571-200111000-00002 Document Type: Article |
Times cited : (34)
|
References (36)
|